SPRINTR is a national initiative for research and coordination in the development of precision medicine. SPRINTR gathers actors from across the country to become a research infrastructure for the development and validation of biomarker-driven treatment strategies in cancer.
SPRINTR Research
SPRINTR research is designed to accelerate precision medicine in prostate cancer. It will facilitate high quality biomarker research, clinical trial design, recruitment, and follow-up, drug discovery, and health economy and quality of life assessment. It comprises four integrated parts, all adding critial components to the open research infrastructure.
SPRINTR-Retro
Retrospective biomarker evaluation in performed clinical trials
SPRINTR-Real
SPRINTR-Trial
SPRINTR-Next
SPRINTR is creating a scalable infrastructure to ensure safe, flexible, and smart data solutions for researchers and industry.
SPRINTR is based on the national multidisciplinary research network, clinical speciality networks, and close collaboration with patient organization and other national infrastructures in precision medicine
Steering Group
SPRINTR's Steering Group drives strategic direction, sets priorities, and shapes the long-term development of our collective work.
Avisory Board
SPRINTR's Advisory Board offers independent expert guidance across scientific, strategic, and methodological questions.
Collaborations
SPRINTR collaborates with Swedish infrastructures as well as researchers, authorities, and companies within the field of life science and precision medicine
Funding
SPRINTR studies and infrastructure are funded by different sources, but the main contribution to the whole SPRINTR is from Sjöbergstiftelsen
Management of SPRINTR infrastructure, data, communication, and administration